Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Biotech
Big Pharma ROI for drug R&D saw surprise rebound in 2023: report
The 2023 figures are now in and they suggest the picture isn’t as bleak as feared
James Waldron
Apr 25, 2024 12:01am
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Feb 1, 2024 11:30am
Equillium swaps subcutaneous cytokine inhibitor for oral option
Dec 21, 2023 10:58am
Lumos stock rockets on oral growth hormone phase 2 results
Nov 8, 2023 9:40am
AstraZeneca's failed cancer drug gets new life in CKD trial
Nov 3, 2023 11:30am